How to evaluate antiarrhythmic agents in an essentially asymptomatic population.
Connolly
S
S
Faculty of Health Sciences, McMaster University, Hamilton, Ontario.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology; D002170:Canada; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications*; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000209:etiology; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents